Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Madura J. Rangaraj"'
1
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
Autor: Gerd R Burmester, Piotr Leszczyński, Charles Ludivico, Georgia Roane, Min Bao, Madura J. Rangaraj, Alain Cantagrel, Andrea Rubbert-Roth, Eduardo Mysler, Lucy Rowell, Peng Lu, Stephen B. Hall, Daniel Feldman
Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Annals of the Rheumatic Diseases
Roche. F. Hoffmann-La Roche, Ltd (Roche) Objectives This study compared the efficacy and safety of subcutaneous (SC) versus intravenous (IV) formulations of tocilizumab in patients with rheumatoid arthritis with an inadequate response to disease-modi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041ef20aa8431709510830efd2cccfb3
https://doi.org/10.1136/annrheumdis-2013-203523
Zobrazit plný text záznamu
2
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
Autor: Madura J. Rangaraj, Charles Ludivico, Georgia Roane, Daniel Feldman, Lucy Rowell, Piotr Leszczyński, Andrea Rubbert-Roth, Stephen B. Hall, Min Bao, Eduardo Mysler, Gerd R Burmester, Alain Cantagrel, Claire Davies
Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Annals of the Rheumatic Diseases
Roche F. Hoffmann-La Roche, Ltd. Objectives To evaluate the long-term efficacy and safety of subcutaneous (SC) tocilizumab (TCZ) versus intravenous (IV) TCZ, including switching formulations, in patients with rheumatoid arthritis (RA) and inadequate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9656a693216da8c7d42d3e0c5c34044c
http://repositorio.unifesp.br/handle/11600/49698
Zobrazit plný text záznamu
5
SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
Autor: I. Vranic, Gerd-Rüdiger Burmester, Daniel Feldman, Lucy Rowell, Andrea Rubbert-Roth, Alain Cantagrel, Madura J. Rangaraj, Charles Ludivico, Stephen B. Hall, Georgia Roane, Eduardo Mysler, Piotr Leszczyński
Publikováno v: Annals of the Rheumatic Diseases. 72:A615.2-A615
Background The efficacy and safety profile of intravenous (IV) tocilizumab (TCZ) has been well established in patients (pts) with rheumatoid arthritis (RA). The aim of a subcutaneous (SC) TCZ dosing regimen is to provide the convenience of patient ho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10388ce58a296b8ddd589226c8098537
https://doi.org/10.1136/annrheumdis-2013-eular.1831
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje